These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11333928)

  • 21. Intestinal mucosal immunoglobulins during human immunodeficiency virus type 1 infection.
    Janoff EN; Jackson S; Wahl SM; Thomas K; Peterman JH; Smith PD
    J Infect Dis; 1994 Aug; 170(2):299-307. PubMed ID: 8035014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IgA antibodies to human immunodeficiency virus in serum, saliva and urine for early diagnosis of immunodeficiency virus infection in Ugandan infants.
    Morgado de Moura Machedo JE; Kayita J; Bakaki P; Coulter JB; Ndugwa CM; Tindyebwa D; Hart CA
    Pediatr Infect Dis J; 2003 Feb; 22(2):193-5. PubMed ID: 12613456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficient neutralization of primary isolates by the plasma from HIV-1 infected Indian children.
    Prakash SS; Chaudhary AK; Lodha R; Kabra SK; Vajpayee M; Hazarika A; Bagga B; Luthra K
    Viral Immunol; 2011 Oct; 24(5):409-13. PubMed ID: 22004138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and characterization of sera from HIV-infected individuals with broad cross-neutralizing activity against group M (env clade A-H) and group O primary HIV-1 isolates.
    Beirnaert E; Nyambi P; Willems B; Heyndrickx L; Colebunders R; Janssens W; van der Groen G
    J Med Virol; 2000 Sep; 62(1):14-24. PubMed ID: 10935983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutralizing monoclonal antibodies to human immunodeficiency virus type 1 do not inhibit viral transcytosis through mucosal epithelial cells.
    Chomont N; Hocini H; Gody JC; Bouhlal H; Becquart P; Krief-Bouillet C; Kazatchkine M; Bélec L
    Virology; 2008 Jan; 370(2):246-54. PubMed ID: 17920650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Scarcity or absence of humoral immune responses in the plasma and cervicovaginal lavage fluids of heavily HIV-1-exposed but persistently seronegative women.
    Mestecky J; Wright PF; Lopalco L; Staats HF; Kozlowski PA; Moldoveanu Z; Alexander RC; Kulhavy R; Pastori C; Maboko L; Riedner G; Zhu Y; Wrinn T; Hoelscher M
    AIDS Res Hum Retroviruses; 2011 May; 27(5):469-86. PubMed ID: 21091128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mucosal immune responses in four distinct compartments of women infected with human immunodeficiency virus type 1: a comparison by site and correlation with clinical information.
    Artenstein AW; VanCott TC; Sitz KV; Robb ML; Wagner KF; Veit SC; Rogers AF; Garner RP; Byron JW; Burnett PR; Birx DL
    J Infect Dis; 1997 Feb; 175(2):265-71. PubMed ID: 9203646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection.
    Pilgrim AK; Pantaleo G; Cohen OJ; Fink LM; Zhou JY; Zhou JT; Bolognesi DP; Fauci AS; Montefiori DC
    J Infect Dis; 1997 Oct; 176(4):924-32. PubMed ID: 9333150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early impairment of gut mucosal immunity in HIV-1-infected children.
    Quesnel A; Moja P; Blanche S; Griscelli C; Genin C
    Clin Exp Immunol; 1994 Sep; 97(3):380-5. PubMed ID: 7915975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibodies to human immunodeficiency virus in vaginal secretions of heterosexual women.
    Belec L; Georges AJ; Steenman G; Martin PM
    J Infect Dis; 1989 Sep; 160(3):385-91. PubMed ID: 2760496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potent neutralizing serum immunoglobulin A (IgA) in human immunodeficiency virus type 2-exposed IgG-seronegative individuals.
    Lizeng Q; Nilsson C; Sourial S; Andersson S; Larsen O; Aaby P; Ehnlund M; Björling E
    J Virol; 2004 Jul; 78(13):7016-22. PubMed ID: 15194778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. False positivity of enzyme-linked immunosorbent assay for measurement of secretory IgA antibodies directed at HIV type 1 antigens.
    Jackson S; Prince S; Kulhavy R; Mestecky J
    AIDS Res Hum Retroviruses; 2000 Apr; 16(6):595-602. PubMed ID: 10777150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human immunodeficiency virus type 1 IgA antibody in breast milk and serum.
    Duprat C; Mohammed Z; Datta P; Stackiw W; Ndinya-Achola JO; Kreiss JK; Holmes KK; Plummer FA; Embree JE
    Pediatr Infect Dis J; 1994 Jul; 13(7):603-8. PubMed ID: 7970947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors.
    Montefiori DC; Pantaleo G; Fink LM; Zhou JT; Zhou JY; Bilska M; Miralles GD; Fauci AS
    J Infect Dis; 1996 Jan; 173(1):60-7. PubMed ID: 8537683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cervicovaginal overproduction of specific IgG to human immunodeficiency virus (HIV) contrasts with normal or impaired IgA local response in HIV infection.
    Bélec L; Dupré T; Prazuck T; Tévi-Bénissan C; Kanga JM; Pathey O; Lu XS; Pillot J
    J Infect Dis; 1995 Sep; 172(3):691-7. PubMed ID: 7658060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absence of specific mucosal antibody responses in HIV-exposed uninfected sex workers from the Gambia.
    Dorrell L; Hessell AJ; Wang M; Whittle H; Sabally S; Rowland-Jones S; Burton DR; Parren PW
    AIDS; 2000 Jun; 14(9):1117-22. PubMed ID: 10894275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neutralization of HIV infection by serum IgA antibodies.
    Kozlowski P; Buckheit RW; Jackson S
    Adv Exp Med Biol; 1995; 371B():1027-30. PubMed ID: 7502745
    [No Abstract]   [Full Text] [Related]  

  • 38. Detection of mucosal antibodies in HIV type 1-infected individuals.
    Wright PF; Kozlowski PA; Rybczyk GK; Goepfert P; Staats HF; VanCott TC; Trabattoni D; Sannella E; Mestecky J
    AIDS Res Hum Retroviruses; 2002 Nov; 18(17):1291-300. PubMed ID: 12487817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-IgG antibodies from sera of healthy individuals neutralize HIV-1 primary isolates.
    Metlas R; Srdic T; Veljkovic V
    Curr HIV Res; 2007 Mar; 5(2):261-5. PubMed ID: 17346139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative study of antibodies that are associated with disease progression in HIV disease.
    Tóth FD; Süsal C; Ujhelyi E; Bánhegyi D; Kiss J; Daniel V; Nagy I; Opelz G; Füst G
    Immunol Lett; 1994 Jun; 41(1):33-6. PubMed ID: 7959901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.